ALPHA-CYPERONE


Synonyms	Alpha-Cyperone
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	KUFXJZXMWHNCEH-DOMZBBRYSA-N
Smiles	CC(=C)[C@@H]1CC[C@@]2(C)CCC(=O)C(=C2C1)C
InChI	InChI=1S/C15H22O/c1-10(2)12-5-7-15(4)8-6-14(16)11(3)13(15)9-12/h12H,1,5-9H2,2-4H3/t12-,15+/m1/s1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C15H22O
Molecular Weight	218.33
AlogP	3.95
Hydrogen Bond Acceptor	1.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	1.0
Polar Surface Area	17.07
Molecular species	None
Aromatic Rings	0.0
Heavy Atoms	16.0

Assay Description	Organism	Bioactivity
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality measured after 24 hr	Drosophila melanogaster	4.99 umol/ml
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 37.6 umol/ml measured after 72 hr (Rvb = 3.33 +/-0.33%)	Drosophila melanogaster	100.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 37.6 umol/ml measured after 48 hr (Rvb = 0%)	Drosophila melanogaster	100.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 37.6 umol/ml measured after 24 hr (Rvb = 0%)	Drosophila melanogaster	96.7 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 18.3 umol/ml measured after 72 hr (Rvb = 0%)	Drosophila melanogaster	100.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 18.3 umol/ml measured after 48 hr (Rvb = 0%)	Drosophila melanogaster	100.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 18.3 umol/ml measured after 24 hr (Rvb = 0%)	Drosophila melanogaster	83.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 8.3 umol/ml measured after 72 hr (Rvb = 0%)	Drosophila melanogaster	100.0 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 8.3 umol/ml measured after 48 hr (Rvb = 0%)	Drosophila melanogaster	76.6 %
Insecticidal activity against first-instar larval stage of Drosophila melanogaster fed with artificial diet containing compound assessed as mortality at 8.3 umol/ml measured after 24 hr (Rvb = 0%)	Drosophila melanogaster	70.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL1939885
PubChem	6452086
SureChEMBL	SCHEMBL8170833

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).